MARKET

TORC

TORC

resTORbio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.67
-0.11
-1.07%
Opening 14:56 09/20 EDT
OPEN
9.73
PREV CLOSE
9.77
HIGH
9.92
LOW
9.55
VOLUME
56.46K
TURNOVER
--
52 WEEK HIGH
16.66
52 WEEK LOW
6.21
MARKET CAP
271.07M
P/E (TTM)
-6.9031
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TORC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TORC News

  • Morgan Stanley sees 23% upside in Galapagos in premarket analyst action
  • Seeking Alpha - Article.09/09 12:51
  • Cantor Fitzgerald Initiates Coverage On resTORbio with Overweight Rating, Announces $23 Price Target
  • Benzinga.09/09 10:50
  • resTORbio (TORC) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
  • Seeking Alpha - Article.08/15 19:42
  • resTORbio EPS misses by $0.12
  • seekingalpha.08/14 16:36

More

Industry

Pharmaceuticals
+1.25%
Pharmaceuticals & Medical Research
+1.11%

Hot Stocks

Name
Price
%Change

About TORC

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1 (TORC1). Its initial focus is on the development of RTB101, an orally administered, small molecule, potent TORC1 inhibitor, alone and in combination with other mTOR inhibitors, such as everolimus. Its product pipeline includes the TORC1 program that includes the development of RTB101 for various indications. The indications include respiratory tract infections, heart failure with preserved ejection fraction, autophagy related neurodegenerative diseases and other indications. The Company is developing RTB101 in a Phase II b clinical trial.
More

Webull offers resTORbio, Inc. (TORC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.